{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:47:00Z","timestamp":1788302820712,"version":"build-2803163510"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Although hepatic production of FGF23 has been suggested in chronic settings, there are no data indicating hypophosphatemia resulting from acute hepatic FGF23 production. Based on two clinical observations of profound hypophosphatemia in the setting of acute hepatitis, our study investigates the hypothesis of acute FGF23 liver expression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Retrospective analyses were conducted to estimate FGF23 liver expression both qualitatively (in situ hybridization) and quantitatively (relative FGF23 gene expression and protein production) on histological specimens of human and murine acute hepatitis livers, compared with controls of hepatic fibrosis or healthy liver.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The index clinical case involves acute alcoholic hepatitis complicated by profound hypophosphatemia due to phosphate diabetes, revealing a major production of both FGF23 C-terminal fraction (cFGF23) and bio-intact form (iFGF23, 39\u2009751 RU\/mL, N: 21\u201391; and 228.6 pg\/mL, N: 22.7\u201393.1, respectively). A second case of acute hepatitis related to erythrocytic protoporphyria also exhibited comparable abnormalities. In both cases, no other cause of renal phosphate wasting was identified, and the hydroelectrolytic disorders disappeared in parallel with normalization of the liver balance and FGF23 levels. Histological data of acute hepatitis compared with cirrhosis and healthy liver confirmed our hypothesis of hepatic FGF23 overproduction. Furthermore, mouse models showed a significant increase in FGF23 mRNA relative liver expression in acute hepatitis and a moderate increase in cirrhosis, compared with healthy liver (respectively 60.55\u00a0\u00b1\u00a016.75 and 3.70\u00a0\u00b1\u00a00.87 vs 1.00\u00a0\u00b1\u00a00.65, both P\u00a0&amp;lt;\u00a0.05). These findings were also confirmed at the protein level.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This translational study raises the hypothesis of renal phosphate wasting induced by excessive hepatic production of FGF23 in case of acute hepatitis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfae307","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T11:21:22Z","timestamp":1728559282000},"source":"Crossref","is-referenced-by-count":3,"title":["Severe hypophosphatemia induced by excessive production of FGF23 in acute hepatitis: from bedside to bench"],"prefix":"10.1093","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4988-206X","authenticated-orcid":false,"given":"Aghiles","family":"Hamroun","sequence":"first","affiliation":[{"name":"Nephrology, Public Health-Epidemiology, Lille University Hospital Center , Lille ,","place":["France"]},{"name":"UMR1167 RID-AGE, Institut Pasteur de Lille, Inserm, Lille University, Lille University Hospital Center , Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihad","family":"Boukrout","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille , UMR9020-U1277 \u2013 CANTHER \u2013 Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Cauffiez","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille , UMR9020-U1277 \u2013 CANTHER \u2013 Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Fellah","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille , UMR9020-U1277 \u2013 CANTHER \u2013 Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Van der Hauwaert","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille , UMR9020-U1277 \u2013 CANTHER \u2013 Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pottier","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille , UMR9020-U1277 \u2013 CANTHER \u2013 Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romuald","family":"Mentaverri","sequence":"additional","affiliation":[{"name":"Amiens University Hospital, Human Biology Center , Amiens ,","place":["France"]},{"name":"UR 7517 UPJV, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications (MP3CV), Picardie Jules Verne University , Amiens ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1175-0440","authenticated-orcid":false,"given":"Jeremy","family":"Zaworski","sequence":"additional","affiliation":[{"name":"Inserm, UMR S 1155, Physiology Unit, H\u00f4pital Tenon, Sorbonne Universit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Gnemmi","sequence":"additional","affiliation":[{"name":"Service d'Anatomie Pathologique , Centre de Biologie Pathologique, CHU Lille, Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Gibier","sequence":"additional","affiliation":[{"name":"Service d'Anatomie Pathologique , Centre de Biologie Pathologique, CHU Lille, Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Letavernier","sequence":"additional","affiliation":[{"name":"Inserm, UMR S 1155, Physiology Unit, H\u00f4pital Tenon, Sorbonne Universit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Louvet","sequence":"additional","affiliation":[{"name":"Liver Unit, Lille University Hospital Center , Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Prov\u00f4t","sequence":"additional","affiliation":[{"name":"Nephrology, Lille University Hospital Center , Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Lenain","sequence":"additional","affiliation":[{"name":"Nephrology, Lille University Hospital Center , Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Maanaoui","sequence":"additional","affiliation":[{"name":"Nephrology, Lille University Hospital Center , Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Glowacki","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille , UMR9020-U1277 \u2013 CANTHER \u2013 Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille ,","place":["France"]},{"name":"Nephrology, Lille University Hospital Center , Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Lionet","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille , UMR9020-U1277 \u2013 CANTHER \u2013 Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille ,","place":["France"]},{"name":"Nephrology, Lille University Hospital Center , Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"2024112912171598000_bib1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.amjmed.2005.02.014","article-title":"Hypophosphatemia: an update on its etiology and treatment","volume":"118","author":"Gaasbeek","year":"2005","journal-title":"Am J Med"},{"key":"2024112912171598000_bib2","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1681\/ASN.2007020143","article-title":"Hypophosphatemia: clinical consequences and management","volume":"18","author":"Brunelli","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2024112912171598000_bib3","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00134-013-2970-4","article-title":"Incidence and aetiology of renal phosphate loss in patients with hypophosphatemia in the intensive care unit","volume":"39","author":"Bech","year":"2013","journal-title":"Intensive Care Med"},{"key":"2024112912171598000_bib4","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2215\/CJN.09750913","article-title":"Renal control of calcium, phosphate, and magnesium homeostasis","volume":"10","author":"Blaine","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024112912171598000_bib5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41581-019-0159-y","article-title":"Mechanisms of phosphate transport","volume":"15","author":"Levi","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2024112912171598000_bib6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00424-020-02370-9","article-title":"Expression of NaPi-IIb in rodent and human kidney and upregulation in a model of chronic kidney disease","volume":"472","author":"Motta","year":"2020","journal-title":"Pflugers Arch"},{"key":"2024112912171598000_bib7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/metabo12050401","article-title":"Shedding light on the complex regulation of FGF23","volume":"12","author":"Vervloet","year":"2022","journal-title":"Metabolites"},{"key":"2024112912171598000_bib8","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1681\/ASN.2017121334","article-title":"Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: a meta-analysis","volume":"29","author":"Marthi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2024112912171598000_bib9","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"2024112912171598000_bib10","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/j.amjmed.2020.06.032","article-title":"A challenging case of tumor-induced osteomalacia","volume":"134","author":"Paccou","year":"2021","journal-title":"Am J Med"},{"key":"2024112912171598000_bib11","doi-asserted-by":"publisher","first-page":"e20154453","DOI":"10.1542\/peds.2015-4453","article-title":"Two case reports of FGF23-induced hypophosphatemia in childhood biliary atresia","volume":"138","author":"Wasserman","year":"2016","journal-title":"Pediatrics"},{"key":"2024112912171598000_bib12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.7150\/ijbs.23256","article-title":"FGF23 and fetuin-A interaction in the liver and in the circulation","volume":"14","author":"Mattinzoli","year":"2018","journal-title":"Int J Biol Sci"},{"key":"2024112912171598000_bib13","doi-asserted-by":"publisher","first-page":"e66182","DOI":"10.1371\/journal.pone.0066182","article-title":"Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list","volume":"8","author":"Pri\u00e9","year":"2013","journal-title":"PLoS One"},{"key":"2024112912171598000_bib14","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1210\/jc.2018-00123","article-title":"Hepatic production of fibroblast growth factor 23 in autosomal dominant polycystic kidney disease","volume":"103","author":"Bienaim\u00e9","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2024112912171598000_bib15","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"2024112912171598000_bib16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"2024112912171598000_bib17","doi-asserted-by":"publisher","first-page":"e1003291","DOI":"10.1371\/journal.pgen.1003291","article-title":"miR-199a-5p is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1","volume":"9","author":"Lino Cardenas","year":"2013","journal-title":"PLoS Genet"},{"key":"2024112912171598000_bib18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"2024112912171598000_bib19","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1053\/j.gastro.2020.07.036","article-title":"FXR isoforms control different metabolic functions in liver cells via binding to specific DNA motifs","volume":"159","author":"Ramos Pittol","year":"2020","journal-title":"Gastroenterology"},{"key":"2024112912171598000_bib20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.14712\/fb2009055060243","article-title":"Methods of RNA purification. All ways (should) lead to Rome","volume":"55","author":"Vomelov\u00e1","year":"2009","journal-title":"Folia Biol (Praha)"},{"key":"2024112912171598000_bib21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.21037\/hbsn.2015.12.13","article-title":"Hypophosphatemia and recovery of post-hepatectomy liver insufficiency","volume":"5","author":"Hallet","year":"2016","journal-title":"Hepatobiliary Surg Nutr"},{"key":"2024112912171598000_bib22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1681\/ASN.2013060569","article-title":"Hepatectomy-related hypophosphatemia: a novel phosphaturic factor in the liver-kidney axis","volume":"25","author":"Nomura","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2024112912171598000_bib23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2021.07.003","article-title":"Hypophosphatemia in acute liver failure of a broad range of etiologies is associated with phosphaturia without kidney damage or phosphatonin elevation","volume":"238","author":"Zechner","year":"2021","journal-title":"Transl Res"},{"key":"2024112912171598000_bib24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.kint.2019.04.009","article-title":"Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation","volume":"96","author":"Egli-Spichtig","year":"2019","journal-title":"Kidney Int"},{"key":"2024112912171598000_bib25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int"},{"key":"2024112912171598000_bib26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1056\/NEJMoa0905647","article-title":"A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome","volume":"362","author":"Magen","year":"2010","journal-title":"N Engl J Med"},{"key":"2024112912171598000_bib27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/qjmed\/hcr247","article-title":"Oncogenic osteomalacia, raised FGF-23, and renal Fanconi syndrome","volume":"107","author":"Norden","year":"2014","journal-title":"QJM"},{"key":"2024112912171598000_bib28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s40618-020-01371-w","article-title":"The genetic polymorphisms of XPR1 and SCL34A3 are associated with Fanconi syndrome in Chinese patients of tumor-induced osteomalacia","volume":"44","author":"Jiang","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"2024112912171598000_bib29","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1093\/ndt\/gfu377","article-title":"Renal Fanconi syndrome: taking a proximal look at the nephron","volume":"30","author":"Klootwijk","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2024112912171598000_bib30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/cs0800071","article-title":"Abnormal renal glucose handling in X-linked hypophosphataemic mice","volume":"80","author":"M\u00fchlbauer","year":"1991","journal-title":"Clin Sci (Lond)"},{"key":"2024112912171598000_bib31","doi-asserted-by":"publisher","first-page":"e2022841118","DOI":"10.1073\/pnas.2022841118","article-title":"Orphan nuclear receptor ERR-\u03b3 regulates hepatic FGF23 production in acute kidney injury","volume":"118","author":"Radhakrishnan","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024112912171598000_bib32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.gendis.2022.06.003","article-title":"Acute liver injury induces expression of FGF23 in hepatocytes via orphan nuclear receptor ERR\u03b3 signaling","volume":"10","author":"Jung","year":"2023","journal-title":"Genes Dis"},{"key":"2024112912171598000_bib33","doi-asserted-by":"publisher","first-page":"e0264743","DOI":"10.1371\/journal.pone.0264743","article-title":"Mouse liver injury induces hepatic macrophage FGF23 production","volume":"17","author":"Kumar","year":"2022","journal-title":"PLoS One"},{"key":"2024112912171598000_bib34","doi-asserted-by":"publisher","first-page":"100176","DOI":"10.1016\/j.jhepr.2020.100176","article-title":"Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment","volume":"3","author":"Zaccherini","year":"2021","journal-title":"JHEP Rep"},{"key":"2024112912171598000_bib35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","article-title":"Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis","volume":"69","author":"Brandl","year":"2018","journal-title":"J Hepatol"},{"key":"2024112912171598000_bib36","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"key":"2024112912171598000_bib37","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","article-title":"Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men","volume":"70","author":"Nishida","year":"2006","journal-title":"Kidney Int"},{"key":"2024112912171598000_bib38","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024112912171598000_bib39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1053\/jlts.2003.50053","article-title":"Serum phosphorus levels predict clinical outcome in fulminant hepatic failure","volume":"9","author":"Chung","year":"2003","journal-title":"Liver Transpl"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfae307\/59661493\/sfae307.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/11\/sfae307\/60899162\/sfae307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/11\/sfae307\/60899162\/sfae307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T12:17:32Z","timestamp":1732882652000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfae307\/7816376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfae307","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,10,9]]},"article-number":"sfae307"}}